GTEx Consortium

GTEx Consortium
Name	GTEx Consortium
Formation	2010s
Purpose	Human genomics, transcriptomics, eQTL mapping
Headquarters	United States
Parent organization	National Institutes of Health

GTEx Consortium The GTEx Consortium is a large-scale biomedical research collaboration that characterized human gene expression across tissues to map expression quantitative trait loci and regulatory variation. Founded through initiatives led by the National Institutes of Health, the project brought together academic centers, sequencing facilities, biobanks, and computational groups to create a public resource widely used by researchers in genomics, pharmacogenomics, and clinical genetics. Its outputs have informed studies published in venues like Nature, Science, and Cell and have influenced consortia such as the ENCODE Project, 1000 Genomes Project, and the International HapMap Project.

Background and objectives

The consortium was initiated to link germline variation with tissue-specific transcriptional regulation, complementing population genetics efforts exemplified by Human Genome Project, International HapMap Project, and 1000 Genomes Project. Key objectives included mapping expression quantitative trait loci (eQTLs), cataloging splicing QTLs, and enabling interpretation of genome-wide association study (GWAS) loci from efforts like the Wellcome Trust Case Control Consortium and the UK Biobank. The program aligned with priorities from agencies including the National Human Genome Research Institute, National Institute of Mental Health, and National Cancer Institute and collaborated with repositories such as dbGaP and the European Bioinformatics Institute.

Study design and methods

The study combined postmortem tissue procurement, phenotyping, and high-throughput assays performed at centers including the Broad Institute, Sanger Institute, and University of California, Santa Cruz. Tissue collection protocols referenced standards from organizations like the College of American Pathologists and involved partnerships with organ procurement organizations and pathology departments at institutions such as Johns Hopkins Hospital, Massachusetts General Hospital, and Mayo Clinic. Nucleic acid extraction and library preparation used platforms from Illumina and protocols adapted from groups at Stanford University, Harvard Medical School, and University of Pennsylvania. Statistical pipelines incorporated methods developed at Princeton University, University of Chicago, and Cold Spring Harbor Laboratory, leveraging tools and concepts from the 1000 Genomes Project, ENCODE Project, and methods such as linear mixed models used in studies from University of Michigan and EMBL-EBI.

Data generation and resources

GTEx produced multi-tissue RNA sequencing data, genotype arrays, and whole-genome sequencing datasets generated at sequencing centers including Broad Institute Genomics Platform and Baylor College of Medicine Human Genome Sequencing Center. Data releases were coordinated with repositories such as dbGaP, GTEx Portal, and the European Genome-phenome Archive, and complemented annotation from GENCODE, RefSeq, and the UCSC Genome Browser. Computational resources and containerized pipelines invoked software from Ensembl, Bioconductor, and projects at GitHub hosts maintained by groups at University of California, Berkeley and Weill Cornell Medicine.

Key findings and contributions

Analyses identified thousands of cis-eQTLs and trans-eQTLs, clarified alternative splicing regulation, and mapped tissue-sharing patterns building on concepts from Lander Lab and statistical frameworks used in Wellcome Trust projects. Findings connected GWAS loci for traits studied by groups such as the Psychiatric Genomics Consortium, CARDIoGRAM, and GIANT consortium to candidate genes and regulatory mechanisms. The project introduced cross-tissue models influenced by methods from Stanford University and University of California, San Diego, and its atlases have been cited by studies in Alzheimer's Disease research at Columbia University, oncology programs at Memorial Sloan Kettering Cancer Center and Dana-Farber Cancer Institute, and immunology investigations at Rockefeller University.

Governance, collaborations, and funding

The consortium’s governance involved steering committees with participants from academic hubs including Yale University, University of Washington, and University of California, Los Angeles, and coordination with federal programs at National Institutes of Health components. Funding mechanisms encompassed grants from the National Human Genome Research Institute and cooperative agreements with centers such as Broad Institute and Baylor College of Medicine. Collaborators included disease-focused consortia like Alzheimer's Disease Genetics Consortium, population resources such as UK Biobank, and bioresource infrastructures like dbGaP and NIH Data Commons.

Impact and applications

GTEx resources accelerated interpretation of GWAS signals utilized by translational initiatives at Genentech, Regeneron Pharmaceuticals, and academic translational centers such as Vanderbilt University Medical Center. The atlas informed pharmacogenomics research at Food and Drug Administration-linked initiatives and clinical genetics databases like ClinVar and OMIM. Methods and data supported functional follow-ups in labs at MIT, Caltech, and Salk Institute, and enabled integrative analyses with single-cell efforts from Human Cell Atlas groups and epigenomics studies from the ENCODE Project. The resource continues to underpin work in diverse areas including cardiology programs at Cleveland Clinic, metabolic disease studies at Joslin Diabetes Center, and psychiatric genetics consortia including PsychENCODE.

Category:Genomics consortia